MYCOVAC-L^®

Mycoplasma gallisepticum Vaccine

Live Culture 

MYCOVAC-L^® is the patented, live Intervet 6/85 strain of Mycoplasma gallisepticum (MG). The safe, highly immunogenic, lyophilized vaccine is for use via fine spray in chickens for protection against losses associated with MG infection. 

Indications
MYCOVAC-L^® vaccine is indicated for the vaccination of chickens at six weeks of age or older for protection against clinical signs of MG.

Administration and Dosage
The time of administration should be determined by the degree of MG exposure, type of chicken being vaccinated, and the current management procedures. MYCOVAC-L^® vaccine is approved for use via fine spray (less than 20 microns) at 6 weeks of age or older.

Vaccination
The best protection is obtained when the vaccinated chickens have time to develop immunity prior to exposure to MG. Avoid the use of any medications effective against MG for 5 days before or after vaccination. Good management practices are recommended to reduce the exposure to MG for at least 3 weeks following vaccination. Birds should be maintained in a proper environment with good management at all times to maximum vaccine efficacy.

Caution
1. Refer to the package insert for specific directions.
2. Do not medicate chickens with antibacterial drugs--especially chlortetracycline, xytertracycline, and sulfonamid--5 days prior to or after vaccination.
3. This vaccine should not be administered within 2 weeks of any Newcastle, bronchitis or laryngotracheitis vaccination. 
4. All susceptible birds on the same premises should be vaccinated at the same time.
5. Do not dilute the vaccine or otherwise stretch the dosage of the vaccine.
6. Use entire contents of the vial when first opened.
7. Do not vaccinate chickens within 21 days of slaughter.
8. The 6/85 strain is not pathogenic for turkeys, but care should be taken to maintain tight biosecurity during the application of the vaccine and when handling vaccinated chickens.

Supplied
Code: MG-240-2
10 x 2,000 dose vials